Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-26 @ 3:05 AM
Study NCT ID:
NCT05669820
Status:
RECRUITING
Last Update Posted:
2024-02-05
First Post:
2022-12-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Antisecretory Factor Glioblastoma Phase 2
Sponsor:
Peter Siesjö
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-15
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-20
First Submit QC Date:
None
Study First Post Date:
2023-01-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-02
Last Update Post Date:
2024-02-05
Last Update Post Date Type:
ACTUAL